With the announcement of the World Health Organization yesterday of a world wide pandemic it is now more important than ever to keep up our preparations and to increase or efforts to get our family and friends to understand the threat. You may have heard that Novartis has developed a vaccine for the H1N1 flu. There are a few points to pay attention to. Although this is great news, it is just the beginning. Human tests have not been conducted and we all remember the last time a vaccine was rushed to market, in 1976, more deaths occurred from the vaccine than from the flu. I am sure they will conduct complete tests this time and that will take time. Also, they admit production licenses will not happen until the fall, the beginning of the flu season. Manufacture will then take time and we will be unprotected until that time. Thirty countries are awaiting vaccines and all the major vaccine manufacturers have committed a portion of their production to countries that cannot afford to pay for the vaccine. This will limit the supply. Who will decide who among us gets the vaccine and who doesn’t. Vaccines are also being developed by companies using the proven method, although old, of injecting eggs and letting the virus grow in eggs and them creating the vaccine from those cells. This method will not have vaccines available until November or December, far into the flu season.
Self quarantine may be the only option we have to keep our family safe.
We will keep preparing. Last week we discussed when to see the doctor. This week the information on when to go directly to the hospital.
If your family member has any of the following, go to the hospital immediately:
Severe trouble breathing and it is not caused by a stuffy nose
Has blue lips or hands, suddenly becomes pale, or has cold legs up to their knees
Is limp or unable to move
Is so sleepy they don’t respond when you try to get them up
Shows signs of a stiff neck, especially if they also have fever, are listless and their eyes are sensitive to light
Is very confused
Has a seizure
"Novartis has successfully completed the production of the first batch of influenza A(H1N1) vaccine, weeksahead of expectations. Cell-based manufacturing technology[1] allows vaccine production to be initiated once a pandemic virus strain isidentified without the need to adapt the virus strain to grow in eggs, as with traditional vaccine technologies. This advance has cut weeks off the time required to begin vaccine production. This first batch of ten liters of wild type influenza A(H1N1) vaccine monobulk will be used for pre-clinical evaluation and testing and is also being considered for use in clinical trials. It demonstrates the value of the cell-based production approach, that is also being used by Novartis with reassortant influenza A(H1N1) seed."The speed advantages of our cell-based production approach and our unwavering commitment toaddress this public health emergency haveresulted in our ability to provide the fastest possible response to this outbreak," said Dr. Andrin Oswald, CEO of Novartis Vaccines andDiagnostics. "This achievement is also a testament to the technical skills and innovation of Novartis Vaccines and Diagnostics people and our partners. I believe it highlights our reputation as a leader in influenza vaccine research, development and production."Based on this success with the wild type, Novartis expects to be able to achieve rapid scale up of influenza A(H1N1) vaccine manufacturewith reassortant seed which was provided by the Centers for Disease Control and Prevention (CDC) on May 27th. The company plans to start clinical trials with that vaccine in July and expects licensure in the fall of 2009. More than 30 governments have made requests to Novartis to supplythem with influenza A(H1N1) vaccine."
http://www.pr-inside.com/novartis-successfully-demonstrates-capabilities-r1317557.htm
Hey, nice post, really well written. You should write more about this. I’ll certainly be subscribing.